Reference number : 276-2012-2013-Q3-00179, amendment number : , agreement type : C, recipient legal name : ABK BioMedical Incorporated|ABK BioMedical Incorporated, recipient country : CA, recipient province : NS, recipient city : Halifax|Halifax, recipient postal code : B3H 0A8, program name english : Business Development Program, program name french : Programme de développement des entreprises, program purpose english : nan, program purpose french : nan, agreement title english : 201431, agreement title french : 201431, agreement number : 201431, agreement value : 499975.0, agreement start date : 2012-10-12, agreement end date : 2014-10-31, description english : Development of technology to support the treatment of uterine fibroids, description french : Création d'une technologie pour appuyer le traitement des fibromes utérins, expected results english : nan, expected results french : nan, additional information english : The assistance type is Unconditionally Repayable Contribution., additional information french : Le type d'aide est Contribution à remboursement inconditionnel., owner organization : acoa-apeca, owner organization title : Atlantic Canada Opportunities Agency | Agence de promotion économique du Canada atlantique